Cannabinoid derivatives and their use
AssigneeDemeetra Agbio, Inc.
InventorsJohn Crawford, Christopher Chengelis
Life of this patent
Estimating the term…
Abstract
Provided herein are methods of using a compound of Formula (I) or pharmaceutically acceptable salt thereof, for example, in the treatment of a mental health disorder or chronic inflammatory disease.
Claims8
An oral pharmaceutical composition comprising
- (i) a cannabinoid compound, wherein the cannabinoid compound consists of:
- or a pharmaceutically acceptable salt thereof, and
- (ii) a pharmaceutically acceptable carrier.
A method of treating a chronic inflammatory disease in a subject in need thereof, the method comprising orally administering to the subject an oral pharmaceutical composition comprising:
- (i) a cannabinoid compound, wherein the cannabinoid compound consists of:
- and
- (ii) a pharmaceutically acceptable carrier;
- and
- wherein the chronic inflammatory disease is an inflammatory bowel disease.
A method of treating a chronic inflammatory disease in a subject in need thereof, the method comprising orally administering to the subject a composition comprising a cannabinoid compound, wherein the cannabinoid compound consists of:
- and
- wherein the chronic inflammatory disease is an inflammatory bowel disease.
Dependencies are inferred from the claim text.